GEORGE WEAVER: Open Payments
NPI 1164028817 · HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 19 payments from 7 companies in 2025. Trend: 2023 $21 · 2024 $211 · 2025 $484
Food & beverage: $372Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $196 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: AUSTEDO XR, SPRAVATO, REXULTI, CAPLYTA, COBENFY, Auvelity, INGREZZA.
Industry payments across PA — which companies pay providers there.
